본문 바로가기

Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma: A single-center retrospective study in South Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIE
저널 순위
JCR Q3
피인용
Web of Science 3
JCR IF
JCR 2023 1
ISSN
2307-8960

저자

  1. 김태인제1저자Pusan Natl Univ Hosp, Biomed Res Inst, Div Gastroenterol, 179 Gudeok Ro, Busan 49241, South Korea
  2. 한성용Pusan Natl Univ, Coll Med, Dept Internal Med, Yangsan 50612, South Korea
  3. 이종현Pusan Natl Univ Hosp, Biomed Res Inst, Div Gastroenterol, 179 Gudeok Ro, Busan 49241, South Korea
  4. 김동욱A교신저자Pusan Natl Univ, Coll Med, Dept Internal Med, Yangsan 50612, South Korea

초록

BACKGROUND Intrahepatic duct (IHD) stones are among the most important risk factors for cholangiocarcinoma (CCC). Approximately 10% of patients with IHD stones develop CCC; however, there are limited studies regarding the effect of IHD stone removal on CCC development. AIM To investigate the association between IHD stone removal and CCC development. METHODS We retrospectively analyzed 397 patients with IHD stones at a tertiary referral center between January 2011 and December 2020. RESULTS CCC occurred in 36 of the 397 enrolled patients. In univariate analysis, chronic hepatitis B infection (11.1% vs 3.0%, P = 0.03), carbohydrate antigen 19-9 (CA19-9, 176.00 vs 11.96 II/mL, P = 0.010), stone located in left or both lobes (86.1% vs 70.1%, P = 0.042), focal atrophy (52.8% vs 26.9%, P = 0.001), duct stricture (47.2% vs 24.9%, P = 0.004), and removal status of IHD stone (33.3% vs 63.2%, P < 0.001) were significantly different between IHD stone patients with and without CCC. In the multivariate analysis, CA19-9 > upper normal limit, carcinoembryonic antigen > upper normal limit, stones located in the left or both lobes, focal atrophy, and complete removal of IHD stones without recurrence were independent factors influencing CCC development. However, the type of removal method was not associated with CCC risk. CONCLUSION Complete removal of IHD stones without recurrence could reduce CCC risk.

키워드

Intrahepatic bile duct stoneCholangiocarcinomaPercutaneous transhepatic cholangioscopyEndoscopic retrograde cholangiopancreatographyCarbohydrate antigen 19-9HEPATOLITHIASISASPIRINCANCERPREVENTION

식별자

WoS UID
001177421100011